AbCellera to Present Virtually at Upcoming Investor Conferences
12 Aprile 2021 - 10:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the following virtual investor
conferences:
- BMO Biopharma Spotlight Series: Technology-Enabled Drug
Discovery Panel on Friday, April 16, 2021 at 7:00 a.m. Pacific
Time
- 2021 Bloom Burton & Co. Healthcare Investor
Conference on Tuesday, April 20 at 10:30 a.m. Pacific Time
Live audio webcasts of each presentation may be accessed through
links that will be posted on AbCellera’s Investor Relations
website. A replay of each webcast will be available through the
same links following the presentation.
About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and
analyzes natural immune systems to find antibodies that its
partners can develop into drugs to prevent and treat disease.
AbCellera partners with drug developers of all sizes, from large
pharmaceutical to small biotechnology companies, empowering them to
move quickly, reduce costs, and tackle the toughest problems in
drug development. To learn more, please visit us at
www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210412005842/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Kevin
Heyries, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Lug 2023 a Lug 2024